Streamlining Virtual Screening:

Virtual screening is a fundamental aspect of in-silico drug design. It involves the rapid screening of vast compound libraries against target proteins to identify molecules with potential therapeutic activity. Through molecular docking simulations and scoring algorithms, researchers can assess the binding affinity and interactions between drugs and protein targets. This enables them to prioritize compounds for further investigation, significantly reducing the time and resources required for experimental screening.